Episode 48: RapidAI's Effect on Stroke Imaging
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Gregory W. Albers, MD.
Episode 48 of the NeurologyLive
The Mind Moments podcast features exclusive interviews with leaders in the field discussing the latest research and disease management strategies across the breadth of neurology, including epilepsy, multiple sclerosis (MS), Parkinson disease, dementia, sleep disorders, and more.
Episode 48, "RapidAI's Effect on Stroke Imaging," features an exclusive interview with Gregory W. Albers, MD, director, Stanford Stroke Center, and Coyote Foundation Professor of Neurology and Neurological Sciences, Stanford Medical Center, and founder, RapidAI. He shared his insight into the development and clinical use of RapidAI, a platform that leverages artificial intelligence to create enhanced, high-quality images from noncontrast CT, CT angiography, CT perfusion, and MRI diffusion and perfusion data, aiming to expedient diagnoses, treatment, and transfer decisions.
The stories featured in this week's Neurology News Minute, which will give you quick updates on the following developments in neurology, are further detailed here:
Lecanemab Rolling Submission for Alzheimer Disease Initiated by Eisai, Biogen Fenfluramine sNDA Submitted for Lennox-Gastaut Syndrome Atogepant Approved for Episodic Migraine Prevention
EPISODE BREAKDOWN
1:15 – Background on RapidAI and its development
3:30 – Findings from the pivotal DIFFUSE clinical program of the system
9:15 – Immediate future plans for RapidAI's capabilities and use
15:55 – Neurology News Minute
18:50 – RapidAI as a complement to the physician in diagnosis
22:00 – Integrating the RapidAI system across the United States
24:50 – The future use of AI in stroke and neuroimaging
28:00 – Closing thoughts
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Related Articles
Pathophysiology of Myasthenia GravisSeptember 18th 2025
